Antiproliferative agent-45
Antiproliferative agent-45 (compound 9) is a prodrug. Antiproliferative agent-45 exhibits significant anti-proliferative effects for human pancreatic cells in hypoxia but fewer effects in normoxia. Antiproliferative agent-45 can be used for cancer research[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antiproliferative-agent-45.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=NC(N([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)C=C1)=O)OCC3=CC=C(NC([C@@H](NC(C4=CC(SC(Cl)=C5Cl)=C5N4)=O)CN6C=CN=C6[N+]([O-])=O)=O)C=C3
Molecular Formula
C30H25Cl2F2N9O10S
Molecular Weight
812.54
References & Citations
[1]Tsuji T, et al. Enhanced tumor specific drug release by hypoxia sensitive dual-prodrugs based on 2-nitroimidazole. Bioorg Med Chem Lett. 2023 Oct 15;95:129484.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2114442-01 0.1 mL
FITC-Linked Polyclonal Antibody to Complement Component 4 (C4)
Sign In for Pricing
View Details MBS2114442-02 0.2 mL
FITC-Linked Polyclonal Antibody to Complement Component 4 (C4)
Sign In for Pricing
View Details MBS2114442-03 0.5 mL
FITC-Linked Polyclonal Antibody to Complement Component 4 (C4)
Sign In for Pricing
View Details